Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients.
Year: 2003
Type: article
Study design: Clinical Trial
Source: PubMed
Institution: Università Campus Bio-Medico
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2142421083
